Nature Medicine: spinal cord neuroprosthesis eases walking problems in a man with Parkinson's disease

ONWARD Medical/ARC Therapy (ARC-EX / ARC-IM / ARC-BCI)

ONWARD's implantable spinal cord neuroprosthesis, tested first in primates, was implanted in a 62-year-old man with 30 years of Parkinson's disease. Combined with deep brain stimulation and medication, it reduced gait asymmetry and freezing and improved balance.

• Closed-loop spinal neuroprosthesis targets the lumbosacral spinal cord
• Reduced gait asymmetry and freezing while improving balance
• Used alongside deep brain stimulation and existing Parkinson's medication
• First application of the technology for Parkinson's, originally developed for spinal cord injury